National

US FDA approves two gene therapies for sickle cell disease

(Reuters) — The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, making one of them the first treatment in the United States based on the Nobel Prize-winning CRISPR gene editing technology. Casgevy, developed by partners Vertex Pharmaceuticals a…
Read More →

Trending

Weekly Poll

Latest E-edition

Please login to access your e-Edition.

+